Projects per year
Fingerprint
Dive into the research topics where Hannah Choe is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Targeting epigenetic regulation via Bromodomain and Extraterminal (BET) domain inhibition for treatment of GVHD
Choe, H. (PI) & Ranganathan, P. (CoPI)
04/5/21 → 03/31/25
Project: Research
-
Combination ruxolitinib and belumosudil is tolerable and induces responses despite treatment failure as monotherapies
Caputo, J., Peddireddi, A., Bhatta, S., Huang, Y., Bezerra, E., Brammer, J., Larkin, K., Mims, A., Vasu, S., Wall, S. & Choe, H., 2025, In: Leukemia and Lymphoma. 66, 1, p. 131-138 8 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Randomized Phase III SIERRA Trial of 131I-Apamistamab before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML
Gyurkocza, B., Nath, R., Seropian, S., Choe, H., Litzow, M. R., Abboud, C., Koshy, N., Stiff, P., Tomlinson, B., Abhyankar, S., Foran, J., Hari, P., Chen, G., Al-Kadhimi, Z., Kebriaei, P., Sabloff, M., Orozco, J. J., Jamieson, K., Silverman, M. & Van Besien, K. & 20 others, , Jan 10 2025, In: Journal of Clinical Oncology. 43, 2, p. 201-213 13 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk Group
Katsivelos, N., Spyrou, N., Weber, D., Vasova, I., Ayuk, F., Choe, H., Hogan, W., DeFilipp, Z., Qayed, M., Etra, A. M., Sandhu, K., Kraus, S., Olson, T., Hexner, E., Aguayo-Hiraldo, P., Reshef, R., Ullrich, E., Schechter, T., Kitko, C. & Chanswangphuwana, C. & 13 others, , Jan 2025, In: Transplantation and Cellular Therapy. 31, 1, p. 10.e1-10.e9Research output: Contribution to journal › Article › peer-review
-
A Day 14 Endpoint for Acute GVHD Clinical Trials
Spyrou, N., Akahoshi, Y., Kowalyk, S., Morales, G., Beheshti, R., Aguayo-Hiraldo, P., Al Malki, M. M., Ayuk, F., Bader, P., Baez, J., Capellini, A., Choe, H., DeFilipp, Z., Eder, M., Eng, G., Etra, A., Gleich, S., Grupp, S. A., Hexner, E. & Hoepting, M. & 21 others, , Apr 2024, In: Transplantation and Cellular Therapy. 30, 4, p. 421-432 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD
Etra, A., Jurdi, N. E., Katsivelos, N., Kwon, D., Gergoudis, S., Morales, G., Spyrou, N., Kowalyk, S., Aguayo-Hiraldo, P., Akahoshi, Y., Ayuk, F., Baez, J., Betts, B. C., Chanswangphuwana, C., Chen, Y. B., Choe, H., DeFilipp, Z., Gleich, S., Hexner, E. & Hogan, W. J. & 18 others, , Jun 25 2024, In: Blood Advances. 8, 12, p. 3284-3292 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations